Canaccord Genuity Maintains Buy on Merit Medical Systems, Lowers Price Target to $85

Benzinga Newsdesk www.benzinga.com Neutral 45.1%

Neg 0% Neu 45.1% Pos 0%

Canaccord Genuity analyst Jon Young maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and lowers the price target from $90 to $85.